Sartorius Stedim Biotech S.A. (0RG8)
LSE
Real-time Data
07:00 AM
Day's Range
191.9052 wk Range
150.00Overview - 0RG8 - Sartorius Stedim Biotech S.A.
Key Statistics
Valuation
Enterprise Value
20.52B
P/E (Trailing)
‪28.07‬
PEG Ratio
‪3.08‬
Price / Sales (TTM)
‪7.48‬
Price / Book
‪6.85‬
EV / EBITDA
‪23.35‬
Profitability
Gross Margin
‪46.85%‬
Profit Margin
‪15.56%‬
Operating Margin
‪23.22%‬
Return on Assets
‪6.57%‬
Return on Equity
‪18.65%‬
Ownership
Shares Outstanding
97.29M
Float
24.21M
Held by Insiders
‪73.59%‬
Held by Institutions
‪13.94%‬
Price stats
Beta
‪0.47‬
50-Day Avg
‪176.93‬
200-Day Avg
‪182.31‬
Dividends
Payout Ratio
‪20.87%‬
Frequency
Annual
Market Cap - 0RG8 - Sartorius Stedim Biotech S.A.
Peers - 0RG8 - Sartorius Stedim Biotech S.A.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on LSE.
- 0RG8LSESartorius Stedim Biotech S.A.22.13BMarket Cap+8.22%52-week change28.07P/E (Trailing)‪15.56%‬Profit Margin
- CTECLSEConvaTec Group Plc440.00BMarket Cap-3.10%52-week change45.20P/E (Trailing)‪4.97%‬Profit Margin
- MRCLSEMercantile Investment Trust180.45BMarket Cap+11.66%52-week change9.76P/E (Trailing)—Profit Margin
- AGTLSEAVI Global Trust PLC103.63BMarket Cap-0.19%52-week change21.88P/E (Trailing)—Profit Margin
- 0QBOLSEColoplast A/S100.25BMarket Cap-43.01%52-week change19.27P/E (Trailing)‪19.66%‬Profit Margin
- 0OMKLSEEssilorLuxottica74.31BMarket Cap-65.35%52-week change31.25P/E (Trailing)‪9.22%‬Profit Margin
- ATRLSESchroder Asian Total Return Investment Company plc65.35BMarket Cap+27.57%52-week change10.20P/E (Trailing)—Profit Margin
Profile Summary - 0RG8 - Sartorius Stedim Biotech S.A.
About
Sartorius Stedim Biotech S.A. is a leading international provider of innovative equipment and services for the biopharmaceutical industry and life sciences research. The company specializes in single-use technologies, laboratory instruments, consumables, and bioprocess solutions that support the development, quality…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
